|
Market Closed -
London S.E.
03:35:16 14/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.5750 GBX | 0.00% |
|
0.00% | +9.52% |
| 12/11 | EARNINGS AND TRADING: Cavendish cuts dividend; Guardian spin-out | AN |
| 11/11 | Thalia Therapeutics Wraps Up In Vitro Study for Lipisiran Cardiovascular Program | MT |
Chart: Technical Analysis
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| THAT | Delayed | |
Deutsche Boerse AG
| 0GO | Delayed | |
|
Börse Stuttgart
| 0GO | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bullish |
| Resistance | 0.58 | 0.625 | 0.7 |
| Spread/Res. | -0.86% | -8.00% | -17.86% |
| Spread/Supp. | +4.55% | +4.55% | +4.55% |
| Support | 0.55 | 0.55 | 0.55 |
- Stock Market
- Stocks
- THAT Stock
- Charts Thalia Therapeutics Plc
Select your edition
All financial news and data tailored to specific country editions
